If you want to improve the collaboration with your patients to better control their HAE, we recommend that you advise your patients to use the new HAE TrackR app. Developed by fellow HAE patients at HAE International (HAEi), HAE TrackR is an easy-to-use electronic diary designed to record patient’s HAE attacks, treatments and the impact HAE has on their life and the life of their loved ones. In its first version HAE TrackR is available in the following languages: English, Polish, Norwegian, Swedish, Danish, Portuguese, Spanish, German and French. HAE TrackR is available as a Progressive Web Application (PWA), allowing to access a secure and GDPR compliant electronic diary from any device with a standard internet browser.
HAE TrackR at a glance – Made by patients, for patients
More Info on the HAEi TrackR app here:
- is an easy way to track attacks, treatments, and condition
- provides both patients and physicians with a better decision foundation for planning the management of HAE
- protects the privacy and data of the user – the data gathered by the app is the sole property of the user and is only shared if the user decides to
- is pharma company and product neutral
- can be accessed from its website on a computer, tablet, or smartphone
- will be available in as many languages as possible over time: currently
https://haei.org/resources/apps/
https://haetrackr.org/
Download the app here: https://haei.org/hae-trackr-is-now-live-2/
Read more news from ACARE
- January 26, 2023
The HAE Relay: Expert Exchange video series is designed to provide engaging and informative bite-size content to healthcare professionals who are either new to hereditary angioedema (HAE), or are established [...]
- February 21, 2022
If you want to improve the collaboration with your patients to better control their HAE, we recommend that you advise your patients to use the new HAE TrackR app. Developed [...]
- January 4, 2023
Date: 04 February 2023 to 05 February 2023 Venue: Advanced Pediatrics centre, Postgraduate Institute of Medical Education and Research, Chandigarh India Eligible audience: Angioedema treating physicians, e.g. allergists, dermatologists, [...]
